Premium
Embryolethality and teratogenicity of butyl benzyl phthalate in rats
Author(s) -
Ema Makoto,
Itami Takafumi,
Kawasaki Hironoshin
Publication year - 1992
Publication title -
journal of applied toxicology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.784
H-Index - 87
eISSN - 1099-1263
pISSN - 0260-437X
DOI - 10.1002/jat.2550120305
Subject(s) - teratology , phthalate , pregnancy , resorption , fetus , developmental toxicity , body weight , embryo , gestation , medicine , endocrinology , chemistry , biology , genetics , organic chemistry , microbiology and biotechnology
Pregnant Wistar rats were given butyl benzyl phthalate (BBP) at a dose of 2.0% in the diet on days 0–20, days 0–11 or days 11–20 of pregnancy. Food consumption and body weight gain were decreased in pregnant rats given BBP. Pre‐implantation loss in the BBP‐treated groups was comparable to that in the control and pair‐fed groups. All dams given BBP on days 0–20 or days 0–11 exhibited complete resorption of all the implanted embryos. No increase in post‐implantation loss was found in pregnant rats given BBP on days 11–20. Marked teratogenicity was detected in fetuses of the dams given BBP on days 11–20. Cleft palate and fusion of the sternebrae were predominantly observed. Seventy‐two of the 134 fetuses had a cleft palate. The incidence of malformations in this group was significantly and markedly higher than that in the control and pair‐fed groups. In conclusion, the administration of BBP during the first and second half of pregnancy produced embryolethality and teratogenicity, respectively.